"Colorectal Leakage App" for Early Detection of Anastomotic Leakage After Colorectal Surgeries
Launched by NATIONAL RESEARCH ONCOLOGY AND TRANSPLANTOLOGY CENTER, KAZAKHSTAN · Feb 21, 2024
Trial Information
Current as of July 09, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called the "Colorectal Leakage App," is investigating a new mobile application designed to help doctors quickly identify a problem known as anastomotic leakage after patients have colorectal surgery. Anastomotic leakage occurs when there is a failure at the surgical connection between two parts of the intestine, which can lead to serious complications. The study is taking place at the National Research Oncology Center in Astana, Kazakhstan, and aims to see how effective this app is in catching these leaks early.
To participate in the trial, individuals must be 18 years or older and scheduled for colorectal surgery, whether for benign or malignant conditions. They will be monitored post-surgery using the app to ensure any leaks are detected as soon as possible. This study is currently recruiting participants, so if you or someone you know fits the eligibility criteria, this could be an important opportunity to contribute to improving patient care following colorectal surgeries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Scheduled patients with benign and malignant colorectal diseases undergoing surgical treatment, including the creation of anastomoses (ileocolic, colocolic, colorectal anastomoses), with or without a preventive stoma.
- • 2. Male and female patients aged 18 years and older.
- • 3. ECOG = 0-2; 6. Satisfactory hematological indicators and parameters of liver and kidney function.
- Exclusion Criteria:
- • 1. Participants under 18 years old.
- • 2. Pregnant, lactating, or planning pregnancy participants.
- • 3. ECOG\>2;
- • 4. Unresctable tumors.
- • 5. Patient's refusal to continue participating in the study..
About National Research Oncology And Transplantology Center, Kazakhstan
The National Research Oncology and Transplantology Center of Kazakhstan is a leading institution dedicated to advancing the fields of oncology and transplant medicine through innovative research and clinical trials. With a commitment to improving patient outcomes, the center collaborates with national and international partners to develop cutting-edge therapies and clinical protocols. Equipped with state-of-the-art facilities and a multidisciplinary team of experts, the center aims to enhance the understanding of cancer treatment and transplantation, ultimately contributing to the global body of knowledge in these critical areas of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Astana, , Kazakhstan
Patients applied
Trial Officials
Meiram Mamlin, MD
Principal Investigator
National Research Oncology Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported